Literature DB >> 28445073

Plasminogen Activator Inhibitor-1 Is Critical in Alcohol-Enhanced Acute Lung Injury in Mice.

Lauren G Poole1,2, Veronica L Massey1,2, Deanna L Siow1,2, Edilson Torres-Gonzáles3, Nikole L Warner4, James P Luyendyk5, Jeffrey D Ritzenthaler3, Jesse Roman3, Gavin E Arteel1,2.   

Abstract

Chronic alcohol exposure is a clinically important risk factor for the development of acute respiratory distress syndrome, the most severe form of acute lung injury (ALI). However, the mechanisms by which alcohol sensitizes the lung to development of this disease are poorly understood. We determined the role of the antifibrinolytic protein plasminogen activator inhibitor-1 (PAI-1) in alcohol enhancement of experimental endotoxin-induced ALI. Wild-type, PAI-1-/-, and integrin β3-/- mice were fed ethanol-containing Lieber-DeCarli liquid or a control diet for 6 weeks, followed by systemic LPS challenge. LPS administration triggered coagulation cascade activation as evidenced by increased plasma thrombin-antithrombin levels and pulmonary fibrin deposition. Ethanol-exposed animals showed enhanced PAI-1 expression and pulmonary fibrin deposition with coincident exaggeration of pulmonary inflammatory edematous injury. PAI-1 deficiency markedly reduced pulmonary fibrin deposition and greatly reduced inflammation and injury without impacting upstream coagulation. Interestingly, pulmonary platelet accumulation was effectively abolished by PAI-1 deficiency in ethanol/LPS-challenged mice. Moreover, mice lacking integrin αIIBβ3, the primary platelet receptor for fibrinogen, displayed a dramatic reduction in early inflammatory changes after ethanol/LPS challenge. These results indicate that the mechanism whereby alcohol exaggerates LPS-induced lung injury requires PAI-1-mediated pulmonary fibrin accumulation, and suggest a novel mechanism whereby alcohol contributes to inflammatory ALI by enhancing fibrinogen-platelet engagement.

Entities:  

Keywords:  Serpine1; acute lung injury; alcohol; inflammation

Mesh:

Substances:

Year:  2017        PMID: 28445073      PMCID: PMC5625219          DOI: 10.1165/rcmb.2016-0184OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  44 in total

1.  EFFECTS OF PROLONGED ETHANOL INTAKE: PRODUCTION OF FATTY LIVER DESPITE ADEQUATE DIETS.

Authors:  C S LIEBER; D P JONES; L M DECARLI
Journal:  J Clin Invest       Date:  1965-06       Impact factor: 14.808

2.  Chronic ethanol ingestion impairs alveolar type II cell glutathione homeostasis and function and predisposes to endotoxin-mediated acute edematous lung injury in rats.

Authors:  F Holguin; I Moss; L A Brown; D M Guidot
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

3.  Plasminogen activator inhibitor type-1 deficiency exaggerates LPS-induced acute lung injury through enhancing Toll-like receptor 4 signaling pathway.

Authors:  Feng Hua; Weiying Ren; Lei Zhu
Journal:  Blood Coagul Fibrinolysis       Date:  2011-09       Impact factor: 1.276

4.  Chronic alcohol abuse is associated with an increased incidence of acute respiratory distress syndrome and severity of multiple organ dysfunction in patients with septic shock.

Authors:  Marc Moss; Polly E Parsons; Kenneth P Steinberg; Leonard D Hudson; David M Guidot; Ellen L Burnham; Stephanie Eaton; George A Cotsonis
Journal:  Crit Care Med       Date:  2003-03       Impact factor: 7.598

Review 5.  Plasminogen activator inhibitors--a review.

Authors:  E K Kruithof
Journal:  Enzyme       Date:  1988

Review 6.  The inflammatory role of platelets in cystic fibrosis.

Authors:  Brian P O'Sullivan; Alan D Michelson
Journal:  Am J Respir Crit Care Med       Date:  2005-12-09       Impact factor: 21.405

Review 7.  Alcoholic liver disease and the potential role of plasminogen activator inhibitor-1 and fibrin metabolism.

Authors:  Juliane I Beier; Gavin E Arteel
Journal:  Exp Biol Med (Maywood)       Date:  2012-01

8.  Quantitative proteomics analysis reveals similar release profiles following specific PAR-1 or PAR-4 stimulation of platelets.

Authors:  Thijs C van Holten; Onno B Bleijerveld; Patrick Wijten; Philip G de Groot; Albert J R Heck; Arjan D Barendrecht; Tesy H Merkx; Arjen Scholten; Mark Roest
Journal:  Cardiovasc Res       Date:  2014-04-28       Impact factor: 10.787

Review 9.  Endothelium-platelet interactions in inflammatory lung disease.

Authors:  Arata Tabuchi; Wolfgang M Kuebler
Journal:  Vascul Pharmacol       Date:  2008-06-24       Impact factor: 5.773

Review 10.  Interleukin 8 and acute lung injury.

Authors:  Timothy Craig Allen; Anna Kurdowska
Journal:  Arch Pathol Lab Med       Date:  2013-06-19       Impact factor: 5.534

View more
  9 in total

1.  Chronic + binge alcohol exposure promotes inflammation and alters airway mechanics in the lung.

Authors:  Lauren G Poole; Juliane I Beier; Edilson Torres-Gonzales; Connie F Schlueter; Shanice V Hudson; Amanda Artis; Nikole L Warner; Calvin T Nguyen-Ho; Christine E Dolin; Jeffrey D Ritzenthaler; Gary W Hoyle; Jesse Roman; Gavin E Arteel
Journal:  Alcohol       Date:  2018-11-14       Impact factor: 2.405

2.  Oxygenation impairment in patients with acute aortic dissection is associated with disorders of coagulation and fibrinolysis: a prospective observational study.

Authors:  Zhifeng Gao; Xin Pei; Chen He; Yuefeng Wang; Jiakai Lu; Mu Jin; Weiping Cheng
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

3.  Fibrinogen mediates cadmium-induced macrophage activation and serves as a predictor of cadmium exposure in chronic obstructive pulmonary disease.

Authors:  Fu Jun Li; Ranu Surolia; Pooja Singh; Kevin G Dsouza; Crystal T Stephens; Zheng Wang; Rui-Ming Liu; Sejong Bae; Young-Il Kim; Mohammad Athar; Mark T Dransfield; Veena B Antony
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-02-24       Impact factor: 5.464

4.  Binding domain peptide ameliorates alveolar hypercoagulation and fibrinolytic inhibition in mice with lipopolysaccharide-induced acute respiratory distress syndrome Via NF-κB signaling pathway.

Authors:  Yahui Wang; Yanqi Wu; Bo Liu; Huilin Yang; Hong Qian; Yumei Cheng; Xiang Li; Guixia Yang; Xinghao Zheng; Feng Shen
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

5.  Endothelial METTL3 (Methyltransferase-Like 3) Inhibits Fibrinolysis by Promoting PAI-1 (Plasminogen Activator Inhibitor-1) Expression Through Enhancing Jun Proto-Oncogene N6-Methyladenosine Modification.

Authors:  Qin Bai; Yao Lu; Yanhua Chen; Han Zhang; Weiwei Zhang; Huang Wu; Aiqing Wen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-10-14       Impact factor: 8.311

6.  Antioxidant mitoquinone ameliorates EtOH-LPS induced lung injury by inhibiting mitophagy and NLRP3 inflammasome activation.

Authors:  Wenhua Sang; Sha Chen; Lidan Lin; Nan Wang; Xiaoxia Kong; Jinyan Ye
Journal:  Front Immunol       Date:  2022-08-18       Impact factor: 8.786

7.  Pulmonary coagulation and fibrinolysis abnormalities that favor fibrin deposition in the lungs of mouse antibody-mediated transfusion-related acute lung injury.

Authors:  Yunhong Yu; Peng Jiang; Pan Sun; Na Su; Fangzhao Lin
Journal:  Mol Med Rep       Date:  2021-06-24       Impact factor: 2.952

8.  Do not drink and lyse: alcohol intoxication increases fibrinolysis shutdown in injured patients.

Authors:  Gregory R Stettler; Ernest E Moore; Geoffrey R Nunns; Hunter B Moore; Benjamin R Huebner; Christopher C Silliman; Anirban Banerjee; Angela Sauaia
Journal:  Eur J Trauma Emerg Surg       Date:  2020-03-10       Impact factor: 3.693

Review 9.  Therapeutics targeting the fibrinolytic system.

Authors:  Haili Lin; Luning Xu; Shujuan Yu; Wanjin Hong; Mingdong Huang; Peng Xu
Journal:  Exp Mol Med       Date:  2020-03-09       Impact factor: 8.718

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.